The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Foreign body reaction to biomaterials
Anderson, J. M., Rodriguez, A., & Chang, D. T. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.004 · Cited by 5,138
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Vascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Weidner, N., Carroll, P. R., Flax, J. D., Blumenfeld, W., & Folkman, J. (1993) · PubMed Central · Cited by 1,620
Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., & Redemann, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,620
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Paul Ehrlich's magic bullet concept: 100 years of progress
Strebhardt, K., & Ullrich, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2394 · Cited by 1,457
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
Macheda, M. L., Rogers, S., & Best, J. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20166 · Cited by 1,229
Gordon, A. N., Fleagle, J. T., Guthrie, D., Parkin, D. E., Gore, M. E., & Lacave, A. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3312 · Cited by 1,211
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., & Ruoslahti, E. (2010) · Science · doi:10.1126/science.1183057 · Cited by 1,075
Molecular control of endothelial cell behaviour during blood vessel morphogenesis
Herbert, S. P., & Stainier, D. Y. R. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3176 · Cited by 1,042
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
Qian, Z. M., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,019
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Oerlemans, C., Bult, W., Bos, M., Storm, G., Nijsen, J. F. W., & Hennink, W. E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0233-4 · Cited by 947
Pathophysiological consequences of VEGF-induced vascular permeability
Weis, S. M., & Cheresh, D. A. (2005) · Nature · doi:10.1038/nature03987 · Cited by 909
Enhanced Permeability and Retention (EPR) Effect for Anticancer Nanomedicine Drug Targeting
Greish, K. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-609-2_3 · Cited by 841
Self-citationNanoparticles for drug delivery in cancer treatment
Haley, B., & Frenkel, E. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.015 · Cited by 791
Bae, Y., Nishiyama, N., Fukushima, S., Koyama, H., Yasuhiro, M., & Kataoka, K. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0498166 · Cited by 742
Albumin-bound paclitaxel: a next-generation taxane
Gradishar, W. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1041 · Cited by 712
Impact of Silica Nanoparticle Design on Cellular Toxicity and Hemolytic Activity
Yu, T., Malugin, A., & Ghandehari, H. (2011) · ACS Nano · doi:10.1021/nn2013904 · Cited by 666
Senger, D. R., Perruzzi, C. A., Feder, J., & Dvorak, H. F. (1986) · PubMed · Cited by 646
Folate receptor targeted biodegradable polymeric doxorubicin micelles
Yoo, H. S., & Park, T. G. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.003 · Cited by 620
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
Decuzzi, P., Pasqualini, R., Arap, W., & Ferrari, M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9697-x · Cited by 616
Why are tumour blood vessels abnormal and why is it important to know?
Nagy, J. A., Chang, S.-H., Dvorak, A. M., & Dvorak, H. F. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604929 · Cited by 611
Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
Nishiyama, N., Okazaki, S., Cabral, H., Miyamoto, M., Kato, Y., Sugiyama, Y., Nishio, K., Matsumura, Y., & Kataoka, K. (2003) · PubMed · Cited by 604
Greish, K. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701539584 · Cited by 600
Self-citationFate and behavior of liposomes in vivo: a review of controlling factors.
Senior, J. H. (1987) · PubMed · Cited by 591
Sarin, H. (2010) · Journal of Angiogenesis Research · doi:10.1186/2040-2384-2-14 · Cited by 562
Microvessel quantitation and prognosis in invasive breast carcinoma
Bosari, S., Lee, A. K. C., DeLellis, R. A., Wiley, B. D., Heatley, G. J., & Silverman, M. L. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90344-3 · Cited by 549
Arnida, Janát-Amsbury, M. M., Ray, A., Peterson, C. M., & Ghandehari, H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.010 · Cited by 547
Kedmi, R., Ben-Arie, N., & Peer, D. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.027 · Cited by 546
Lasic, D. D., Martin, F. J., Gabizon, A., Huang, S. K., & Papahadjopoulos, D. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90162-2 · Cited by 545
Maeda, H., Fang, J., Inutsuka, T., & Kitamoto, Y. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00271-0 · Cited by 537
Senior, J., Delgado, C., Fisher, D., Tilcock, C., & Gregoriadis, G. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90337-8 · Cited by 521
Sparreboom, A., Scripture, C. D., Trieu, V., Williams, P. J., De, T., Yang, A., Beals, B., Figg, W. D., Hawkins, M., & Desai, N. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2291 · Cited by 504
Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity
Torchilin, V. P., Omelyanenko, V. G., Papisov, M. I., Bogdanov, A. A., Trubetskoy, V. S., Herron, J. N., & Gentry, C. A. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90003-5 · Cited by 466
Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors
Laginha, K. M., Verwoert, S., Charrois, G. J. R., & Allen, T. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0343 · Cited by 441
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Uchino, H., Matsumura, Y., Negishi, T., Koizumi, F., Hayashi, T., Honda, T., Nishiyama, N., Kataoka, K., Naito, S., & Kakizoe, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602772 · Cited by 430
Heterogeneity of the Tumor Vasculature
Nagy, J., Chang, S.-H., Shih, S.-C., Dvorak, A., & Dvorak, H. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1253454 · Cited by 422
Zhang, Y., Yang, M., Portney, N. G., Cui, D., Budak, G., Ozbay, E., Ozkan, M., & Ozkan, C. S. (2008) · Biomedical Microdevices · doi:10.1007/s10544-007-9139-2 · Cited by 422
Macrophages define the invasive microenvironment in breast cancer
Pollard, J. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107762 · Cited by 417
Schmid, H.-P., McNeal, J. E., & Stamey, T. A. (1993) · Cancer · doi:10.1002/1097-0142(19930315)71:6<2031::aid-cncr2820710618>3.0.co;2-q · Cited by 401
Tumor angiogenesis in advanced stage ovarian carcinoma.
Hollingsworth, H. C., Kohn, E. C., Steinberg, S. M., Rothenberg, M. L., & Merino, M. J. (1995) · Europe PMC (PubMed Central) · Cited by 386
A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics
Takei, Y., Kadomatsu, K., Yuzawa, Y., Matsuo, S., & Muramatsu, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2682 · Cited by 378
Nanomedicines and nanotoxicology: some physiological principles
Garnett, M. C., & Kallinteri, P. (2006) · Occupational Medicine · doi:10.1093/occmed/kql052 · Cited by 352
Transferrin-Containing, Cyclodextrin Polymer-Based Particles for Tumor-Targeted Gene Delivery
Bellocq, N. C., Pun, S. H., Jensen, G. S., & Davis, M. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034125f · Cited by 350
Seymour, L. W., Miyamoto, Y., Maeda, H., Brereton, M., Strohalm, J., Ulbrich, K., & Duncan, R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00514-6 · Cited by 337
Dinndorf, P. A., Gootenberg, J., Cohen, M. H., Keegan, P., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-991 · Cited by 324
Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells
Wang, S., & Low, P. S. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00236-8 · Cited by 295
MAEDA, H. (2012) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.88.53 · Cited by 291
Niki, T., Iba, S., Tokunou, M., Yamada, T., Matsuno, Y., & Hirohashi, S. (2000) · PubMed · Cited by 288
Dixit, V., Van den Bossche, J., Sherman, D. M., Thompson, D. H., & Andres, R. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050335b · Cited by 282
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
Greish, K., Fang, J., Inutsuka, T., Nagamitsu, A., & Maeda, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00002 · Cited by 278
Self-citationNewman, M. S., Colbern, G. T., Working, P. K., Engbers, C., & Amantea, M. A. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050855 · Cited by 275
Lee, T.-H., Seng, S., Sekine, M., Hinton, C., Fu, Y., Avraham, H. K., & Avraham, S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040186 · Cited by 265
Liposome circulation time and tumor targeting: implications for cancer chemotherapy
Gabizon, A. A. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00030-b · Cited by 255
Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
Laakkonen, P., Waltari, M., Holopainen, T., Takahashi, T., Pytowski, B., Steiner, P., Hicklin, D., Persaud, K., Tonra, J. R., Witte, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3567 · Cited by 241
Granulomatous Lung Disease: An Approach to the Differential Diagnosis
Mukhopadhyay, S., & Gal, A. A. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.5.667 · Cited by 240
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel
Immordino, M. L., Brusa, P., Arpicco, S., Stella, B., Dosio, F., & Cattel, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00271-2 · Cited by 238
Smith, N. R., Baker, D., James, N. H., Ratcliffe, K., Jenkins, M., Ashton, S. E., Sproat, G., Swann, R., Gray, N., Ryan, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2797 · Cited by 237
Tumor doubling time and prognostic assessment of patients with primary lung cancer
Usuda, K., Saito, Y., Sagawa, M., Sato, M., Kanma, K., Takahashi, S., Endo, C., Chen, Y., Sakurada, A., & Fujimura, S. (1994) · Cancer · doi:10.1002/1097-0142(19941015)74:8<2239::aid-cncr2820740806>3.0.co;2-p · Cited by 230
Jung, C. W. (1995) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(95)00023-a · Cited by 226
Polymers and nanoparticles: Intelligent tools for intracellular targeting?
Breunig, M., Bauer, S., & Goepferich, A. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.06.010 · Cited by 215
Selective Delivery of Adiramycin to a Solid Tumor Using a Polymeric Micelle Carrier System
Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., Okamoto, K., & Kataoka, K. (1999) · Journal of Drug Targeting · doi:10.3109/10611869909085500 · Cited by 213
Wu, J., Akaike, T., & Maeda, H. (1998) · PubMed · Cited by 212
Liposomal doxorubicin (Doxil): An effective new treatment for Kaposi's sarcoma in AIDS
James, N. D., Coker, R. J., Tomlinson, D., Harris, J. R. W., Gompels, M., Pinching, A. J., & Stewart, J. S. W. (1994) · Clinical Oncology · doi:10.1016/s0936-6555(05)80269-9 · Cited by 205
Xiong, X.-B., Huang, Y., Lu, W.-L., Zhang, X., Zhang, H., Nagai, T., & Zhang, Q. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.030 · Cited by 205
Probing the structural and molecular diversity of tumor vasculature
Pasqualini, R., Arap, W., & McDonald, D. M. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02429-2 · Cited by 205
Macrophages Mediate Inflammation-Enhanced Metastasis of Ovarian Tumors in Mice
Robinson-Smith, T. M., Isaacsohn, I., Mercer, C. A., Zhou, M., Van Rooijen, N., Husseinzadeh, N., McFarland-Mancini, M. M., & Drew, A. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4375 · Cited by 199
Panyam, J., & Labhasetwar, V. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034002c · Cited by 195
Goldmann, E. (1908) · PubMed · Cited by 180
Polymer–drug conjugates: towards a novel approach for the treatment of endrocine-related cancer
Duncan, R., Vicent, M. J., Greco, F., & Nicholson, R. I. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01045 · Cited by 179
Etrych, T., Kovář, L., Strohalm, J., Chytil, P., Říhová, B., & Ulbrich, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.015 · Cited by 173
The EPR Effect and Polymeric Drugs: A Paradigm Shift for Cancer Chemotherapy in the 21st Century
Maeda, H., Greish, K., & Fang, J. (2005) · Advances in Polymer Science · doi:10.1007/12_026 · Cited by 173
Self-citationVascular Hyperpermeability, Angiogenesis, and Stroma Generation
Nagy, J. A., Dvorak, A. M., & Dvorak, H. F. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006544 · Cited by 165
Ng, I. O. L., Poon, R. T. P., Lee, J. M. F., Fan, S. T., Ng, M., & Tso, W. K. (2001) · American Journal of Clinical Pathology · doi:10.1309/fxnl-qtn1-94fh-ab3a · Cited by 163
Vaage, J., Barberá‐Guillem, E., Abra, R. M., Huang, A., & Working, P. K. (1994) · Cancer · Cited by 162
Cabral, H., Nishiyama, N., & Kataoka, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.024 · Cited by 161
MAEDA, H., Takeshita, J., & Kanamaru, R. (1979) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1979.tb01730.x · Cited by 159
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
Timoshenko, A. V., Chakraborty, C., Wagner, G. F., & Lala, P. K. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603067 · Cited by 159
Volumetric Growth Rate of Stage I Lung Cancer prior to Treatment: Serial CT Scanning
Winer-Muram, H. T., Jennings, S. G., Tarver, R. D., Aisen, A. M., Tann, M. A., Conces, D. J., & Meyer, C. A. (2002) · Radiology · doi:10.1148/radiol.2233011026 · Cited by 153
Mifamurtide for the treatment of nonmetastatic osteosarcoma
Ando, K., Mori, K., Corradini, N., Rédiní, F., & Heymann, D. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.543129 · Cited by 150
Peng, C., Lai, P., Lin, F., Wu, S. Y.-H., & Shieh, M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.048 · Cited by 150
Bianco, R., Rosa, R., Damiano, V., Daniele, G., Gelardi, T., Garofalo, S., Tarallo, V., De Falco, S., Melisi, D., Benelli, R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4905 · Cited by 149
Yu, J. L., & Rak, J. W. (2003) · Breast Cancer Research · doi:10.1186/bcr573 · Cited by 146
Zaki, N. M., & Tirelli, N. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.501792 · Cited by 146
Altering the immune response with lipid-based nanoparticles
Landesman‐Milo, D., & Peer, D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.034 · Cited by 142
The Tumor Microenvironment in Non–Small-Cell Lung Cancer
Graves, E. E., Maity, A. M., & Le, Q. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.01.003 · Cited by 142
Schluep, T., Cheng, J., Khin, K. T., & Davis, M. E. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0091-7 · Cited by 142
Shiah, J.-G., Dvořák, M., Kopečková, P., Sun, Y., Peterson, C. M., & Kopec̆ek, J. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00374-9 · Cited by 140
Weigand, M., Hantel, P., Kreienberg, R., & Waltenberger, J. L. (2005) · Angiogenesis · doi:10.1007/s10456-005-9010-0 · Cited by 135
Vascular endothelial growth factor: Basic biology and clinical implications
Ferrara, N., & Keyt, B. A. (1997) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9006-9_9 · Cited by 125
Arai, T., Kuroishi, T., Saito, Y., 栗田, 雄., Naruke, T., & Kaneko, M. (1994) · Japanese Journal of Clinical Oncology · doi:10.1093/oxfordjournals.jjco.a039706 · Cited by 124
Zhang, J., Zhang, Z.-H., Yang, H., Tan, Q., Qin, S.-R., & Qiu, X.-L. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2496-8 · Cited by 123
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin
Schoemaker, N. E., van Kesteren, C., Rosing, H., Jansen, S., Swart, M., Lieverst, J. A., Fraier, D., Breda, M., Pellizzoni, C., Spinelli, R., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600516 · Cited by 122
Conover, C. D., Greenwald, R. B., Pendri, A., Gilbert, C. W., & Shum, K. L. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050837 · Cited by 122
In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy
Garcia‐Bennett, A. E., Nees, M., & Fadeel, B. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.01.023 · Cited by 119
Li, C., Newman, R. A., Wu, Q.-P., Shi, K., Chen, W., Hutto, T. Y., Kan, Z., Brannan, M. D., Charnsangavej, C., & Wallace, S. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800000168 · Cited by 114
Ravindranath, N., Wion, D., Brachet, P., & Djakiew, D. (2001) · Journal of Andrology · doi:10.1002/j.1939-4640.2001.tb02199.x · Cited by 111
Vermeulen, P., Verhoeven, D., Hubens, G., Marck, E. V., Goovaerts, G., Huyghe, M., de Bruijn, E. A., van Oosterom, A. T., & Dirix, L. Y. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059043 · Cited by 106
Tumor Angiogenesis Correlates With Histologic Type and Metastasis in Non-Small-Cell Lung Cancer
Yuan, A., Yang, P., Yu, C., Lee, Y. C., Yao, Y., Chen, C. L., Lee, L., Kuo, S., & Luh, K. T. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.6.8520790 · Cited by 104
Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells
Timoshenko, A. V., Rastogi, S., & Lala, P. K. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603993 · Cited by 102
Polyethylene Glycol-Liposomal Doxorubicin
Sharpe, M., Easthope, S. E., Keating, G. M., & Lamb, H. M. (2002) · Drugs · doi:10.2165/00003495-200262140-00012 · Cited by 96
Pau, E. C. D. S., Arias, F. C., Caso, E., Molina, G. M. M., Hernández, I. S., Trueba, I. M., Balsalobre, R. M., Sacristán, S., Pinillos, A. G., & Toledo-Lobo, M. V. (2009) · Cancer · doi:10.1002/cncr.24193 · Cited by 95
de Menezes, D. E. L., Hudon, N. J., McIntosh, N. L., & Mayer, L. D. (2000) · PubMed · Cited by 93
Angiogenesis in Endometrial Hyperplasia and Stage I Endometrial Carcinoma
Abulafia, O., TRIEST, W., SHERER, D., HANSEN, C., & GHEZZI, F. (1995) · Obstetrics and Gynecology · doi:10.1016/0029-7844(95)00203-4 · Cited by 93
Martinelli, E., Troiani, T., Morgillo, F., Rodolico, G., Vitagliano, D., Morelli, M. P., Tuccillo, C., Vecchione, L., Capasso, A., Orditura, M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0923 · Cited by 90
Tumor Growth Rate and Prognosis of Breast Cancer Mainly Detected by Mass Screening
Kuroishi, T., Tominaga, S., Morimoto, T., Tashiro, H., Itoh, S., Watanabe, H., Fukuda, M., Ota, J., Horino, T., Ishida, T., et al. (1990) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1990.tb02591.x · Cited by 88
Hu, Z., Luo, F., Pan, Y., Hou, C., Ren, L., Chen, J., Wang, J., & Zhang, Y. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31615 · Cited by 82
Zeng, Y., Opeskin, K., Goad, J. R., & Williams, E. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1488 · Cited by 77
High-molecular weight HPMA copolymer–adriamycin conjugates
Dvořák, M., Kopečková, P., & Kopeček, J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00087-5 · Cited by 75
van (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s13482 · Cited by 75
Ozono, S. (2004) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyh011 · Cited by 75
Carcinoma of the Colon and Rectum—Growth Rate
Bolin, S., Nilsson, E., & DAHL, R. S. J. (1983) · Annals of Surgery · doi:10.1097/00000658-198308000-00007 · Cited by 74
Rafi, M., Cabral, H., Kano, M. R., Mi, P., Iwata, C., Yashiro, M., Hirakawa, K., Miyazono, K., Nishiyama, N., & Kataoka, K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.038 · Cited by 71
Sugahara, S.-I., Kajiki, M., Kuriyama, H., & Kobayashi, T. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.009 · Cited by 71
Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.
Behrem, S., Žarković, K., Eškinja, N., & Jonjić, N. (2005) · PubMed · Cited by 66
How Frustration Leads to Inflammation
O'Neill, L. A. J. (2008) · Science · doi:10.1126/science.1158398 · Cited by 65
Growth Rate of Pancreatic Adenocarcinoma: Initial Clinical Experience
Furukawa, H., Iwata, R., & Moriyama, N. (2001) · Pancreas · doi:10.1097/00006676-200105000-00005 · Cited by 65
Goldmann, E. (1908) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591570800101201 · Cited by 64
Contrast agents for hepatic MRI
Morana, G., Salviato, E., & Guarise, A. (2007) · Cancer Imaging · doi:10.1102/1470-7330.2007.9001 · Cited by 63
Polymer Micelles with Hydrazone-Ester Dual Linkers for Tunable Release of Dexamethasone
Howard, M. D., Ponta, A., Eckman, A. M., Jay, M., & Bae, Y. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0470-1 · Cited by 61
Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines
Simiantonaki, N., Jayasinghe, C., Michel-Schmidt, R., Peters, K., Hermanns, M., & Kirkpatrick, C. J. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.3.585 · Cited by 61
Microvessel density as new prognostic marker after radiotherapy in rectal cancer
Švagždys, S., Lesauskaitė, V., Pavalkis, D., Nedzelskienė, I., Pranys, D., & Tamelis, A. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-95 · Cited by 60
Lim, H. J., Masin, D., McIntosh, N. L., Madden, T. D., & Bally, M. B. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35297-8 · Cited by 60
The sinusoidal lining cells in “normal” human liver. A scanning electron microscopic investigation
Horn, T. D., Henriksen, J. H., & Christoffersen, P. (1986) · Liver International · doi:10.1111/j.1600-0676.1986.tb00275.x · Cited by 58
Zhu, Y., Che, L., He, H., Jia, Y., Zhang, J., & Li, X. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.013 · Cited by 58
Experimental studies on the uptake and retention of labelled proteins in a rat tumour
Peterson, H.-I., & Appelgren, K. L. (1973) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(73)90142-4 · Cited by 58
Ward, J. D., Hadfield, M. G., Becker, D. P., & Lovings, E. T. (1974) · Cancer · Cited by 53
Unezaki, S., Maruyama, K., Ishida, O., Suginaka, A., Hosoda, J.-I., & Iwatsuru, M. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04074-9 · Cited by 52
Synthesis, characterization, and tumor selectivity of a polyphosphazene–platinum(II) conjugate
Song, R., Jun, Y. J., Kim, J. I., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.016 · Cited by 52
Tumor Doubling Time of Cutaneous Melanoma and its Metastasis
Carlson, J. A. (2003) · American Journal of Dermatopathology · doi:10.1097/00000372-200308000-00003 · Cited by 51
Morelli, M. P., Brown, A. M., Pitts, T. M., Tentler, J. J., Ciardiello, F., Ryan, A. J., Jürgensmeier, J. M., & Eckhardt, S. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0380 · Cited by 50
Fitzpatrick, T. E., Lash, G. E., Yanaihara, A., Jones, D. S., Macdonald-Goodfellow, S. K., & Graham, C. H. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00044-7 · Cited by 37
Strøm, E., & Larsen, J. L. (1999) · Radiology · doi:10.1148/radiology.211.1.r99ap37211 · Cited by 33
Mezquita, B., Mezquita, J., Pau, M., & Mezquita, C. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22584 · Cited by 32
Zygalaki, E., Tsaroucha, E. G., Kaklamanis, L., & Lianidou, E. S. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.086819 · Cited by 32
Saito, Y., Yasunaga, M., Kuroda, J.-I., Koga, Y., & Matsumura, Y. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.11.014 · Cited by 29
Li, M., Chen, H., Diao, L., Zhang, Y., Xia, C., & Yang, F. (2010) · Tumori Journal · doi:10.1177/030089161009600516 · Cited by 29
Wang, X., Zhao, G., Van, S., Jiang, N., Yu, L., Vera, D. R., & Howell, S. B. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1058-x · Cited by 29
Takahashi, A., Ohkohchi, N., Yasunaga, M., Kuroda, J.-I., Koga, Y., Kenmotsu, H., Kinoshitá, T., & Matsumura, Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1467 · Cited by 26
Colombo, P., Boustta, M., Poujol, S., Pinguet, F., Rouanet, P., Bressolle, F., & Vert, M. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.02.004 · Cited by 25
FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration.
(1996) · PubMed · Cited by 14
Jukanti, R., Devraj, G., Apte, S., & Rambhau, D. (2011) · Journal of Microencapsulation · doi:10.3109/02652048.2010.542496 · Cited by 13
Microvessel density in advanced head and neck squamous cell carcinoma before and after chemotherapy.
Dunphy, F., Stack, B. C., Boyd, J. H., Dunleavy, T. L., Kim, H. J., & Dunphy, C. H. (2002) · PubMed · Cited by 12
Anagnostou, V., TINIAKOS, D. G., Fotinou, M., Achimastos, A. D., & Syrigos, K. N. (2010) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-010-1015-4 · Cited by 9
(1989) · PubMed
Cited by
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Maeda, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.002 · Cited by 1,179
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Rethinking cancer nanotheranostics
Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,102
Metadata
- Authors
- Taurin, S., Nehoff, H., & Greish, K.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 164
- Issue
- 3
- Pages
- 265-275
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2030094610
- Cited by
- 309
- References
- 169
- FWCI
- 11.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.